Advertisement
Advertisement
HURA
TuHURA Biosciences, Inc. Common Stock
3.07
USDSponsored
-0.08
-2.54%
Apr 15, 16:00 UTC -4
Closed
Pre-Market
3.08
+0.02
+0.49%
HURA Earnings Reports
Positive Surprise Ratio
HURA beat 11 of 31 last estimates.
35%
Next Report
Date of Next Report
--
Estimate for Q-- -- (Revenue/ EPS)
--
/--
Implied change from Q4 25 (Revenue/ EPS)
--
/--
Implied change from Q-- -- (Revenue/ EPS)
--
/--
TuHURA Biosciences, Inc. Common Stock earnings per share and revenue
On Mar 31, 2026, HURA reported earnings of -0.17 USD per share (EPS) for Q4 25, missing the estimate of -0.13 USD, resulting in a -28.21% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -9.50% price change (close before vs. close after earnings).
Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Pharvaris N.V. Ordinary Shares
Report Date
Apr 02, 2026 For Q4 25
Estimate
-$0.63
Actual
-$0.72
Surprise
-13.69%
Nurix Therapeutics, Inc. Common stock
Report Date
Apr 08, 2026 For Q1 26
Estimate
-$0.76
Actual
-$0.79
Surprise
-2.68%
NovaBridge Biosciences - ADR
Report Date
Apr 07, 2026 For Q4 25
Estimate
-$0.05
Actual
-$0.28
Surprise
-421.58%
Scilex Holding Company Common Stock
Report Date
Apr 10, 2026 For Q4 25
Estimate
-$0.47
Actual
-$2.21
Surprise
-360.99%
Lexaria Bioscience Corp. Common Stock
Report Date
Apr 13, 2026 For Q2 26
Estimate
-$0.09
Actual
-$0.06
Surprise
+38.08%
Quince Therapeutics, Inc. Common Stock
Report Date
Apr 10, 2026 For Q4 25
Estimate
-$1.92
Actual
-$7.10
Surprise
-268.68%
Sunshine Biopharma Inc.
Report Date
Apr 03, 2026 For Q4 25
Estimate
-$0.27
Actual
-$0.54
Surprise
-96.08%
FAQ
What were TuHURA Biosciences, Inc. Common Stock's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, TuHURA Biosciences, Inc. Common Stock reported EPS of -$0.17, missing estimates by -28.21%, and revenue of $0.00, 0% as expectations.
How did the market react to TuHURA Biosciences, Inc. Common Stock's Q4 2025 earnings?
The stock price moved down -9.5%, changed from $1.79 before the earnings release to $1.62 the day after.
When is TuHURA Biosciences, Inc. Common Stock expected to report next?
The next earning report is scheduled for --.
What are the forecasts for TuHURA Biosciences, Inc. Common Stock's next earnings report?
Based on --
analysts, TuHURA Biosciences, Inc. Common Stock is expected to report EPS of -- and revenue of -- for Q-- --.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement